Esp6, known as exocrine gland secreted peptide 6, plays a crucial role in cellular communication through its involvement in pheromone activity. Situated in the extracellular space, Esp6 is intricately regulated by a diverse set of chemical activators that either directly or indirectly modulate its functions. The activation of Esp6 involves a network of signaling pathways influenced by various chemicals. Direct activators such as Forskolin, Isoproterenol, and Rolipram stimulate Esp6 by up-regulating intracellular cAMP levels, enhancing its pheromone activity in the extracellular space. Additionally, compounds like Phorbol 12-Myristate 13-Acetate (PMA) and Ionomycin activate Esp6 through protein kinase C (PKC) activation and calcium influx, respectively, contributing to increased pheromone activity.
Dibutyryl cAMP mimics the effects of cAMP, while 8-Bromo-cGMP mimics cGMP, both directly up-regulating Esp6 and promoting its role in pheromone signaling. Bay K8644 modulates L-type calcium channels, influencing Esp6 activity and contributing to heightened pheromone activity. Thapsigargin inhibits the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), leading to increased calcium levels and subsequent Esp6 activation. Indirect activators like Iproniazid and Clenproperol influence Esp6 by modulating neurotransmitter levels and beta-adrenergic receptors, respectively, indirectly enhancing pheromone activity in the extracellular space. In conclusion, Esp6 activation involves a sophisticated interplay of chemical activators, each intricately influencing specific pathways to promote its role in pheromone signaling. The diverse set of chemicals presented here sheds light on the nuanced regulatory networks governing Esp6 activity, providing valuable insights into its function in cellular communication through pheromone release in the extracellular space.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol acts as a direct activator, enhancing Esp6 activity by binding to beta-adrenergic receptors and increasing intracellular cAMP. It stimulates pheromone activity in the extracellular space. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram directly activates Esp6 by inhibiting phosphodiesterase, elevating intracellular cAMP levels. It up-regulates Esp6, promoting pheromone activity in the extracellular space. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA acts as a direct activator by activating protein kinase C (PKC), leading to Esp6 up-regulation and enhanced pheromone activity in the extracellular space. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin serves as a direct activator, stimulating Esp6 by inducing calcium influx, leading to increased pheromone activity in the extracellular space. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl cAMP directly activates Esp6 by mimicking the effects of cAMP, up-regulating Esp6 and promoting pheromone activity in the extracellular space. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
Bay K8644 acts as a direct activator, enhancing Esp6 activity by modulating L-type calcium channels, leading to increased pheromone activity in the extracellular space. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cGMP serves as a direct activator of Esp6 by mimicking the effects of cGMP, up-regulating Esp6 and promoting pheromone activity in the extracellular space. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin serves as a direct activator, stimulating Esp6 by inhibiting the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), leading to increased pheromone activity in the extracellular space. | ||||||